Company Monitoring Page for CRISPR-Therapeutics

latest headlines for company on cafepharma

RFK Jr. pledges to divest interests in CRISPR Tx, Dragonfly if HHS role confirmed
Fierce Biotech
Wed, 01/22/25 - 07:03 pm
Tags:
Robert F Kennedy Jr., HHS, CRISPR Therapeutics, Dragonfly Therapeutics
Is anyone taking the world’s priciest drugs?
Pharma Voice
Fri, 08/30/24 - 11:28 am
Tags:
drug prices, gene therapy, CRISPR Therapeutics, Vertex Pharmaceuticals, Sarepta Therapeutics
FDA awarded record number of review designations to CRISPR drugs in 2023
Biopharma Reporter
Tue, 02/6/24 - 09:16 am
Tags:
CRISPR, FDA, gene editing, CRISPR Therapeutics, Vertex Pharmaceuticals
Where Will CRISPR Therapeutics Be in 5 Years?
Motley Fool
Wed, 01/24/24 - 10:54 am
Tags:
CRISPR Therapeutics, gene editing, CRISPR
What’s Next for CRISPR?
BioSpace
Tue, 01/23/24 - 06:00 pm
Tags:
CRISPR, gene editing, Vertex Pharmaceuticals, CRISPR Therapeutics
Could Editas Medicine Become the Next CRISPR Therapeutics?
Motley Fool
Sun, 01/21/24 - 05:01 pm
Tags:
Editas Medicine, gene editing, CRISPR Therapeutics
FDA widens approval of Vertex’s CRISPR medicine to treat beta thalassemia
BioPharma Dive
Wed, 01/17/24 - 09:34 am
Tags:
Vertex Pharmaceuticals, CRISPR Therapeutics, Casgevy, beta thalassemia, FDA
Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval
Clinical Trials Arena
Wed, 01/17/24 - 09:30 am
Tags:
CRISPR, gene editing, clinical trials, Casgevy, Vertex Pharmaceuticals, CRISPR Therapeutics, EdiGene, Shanghai Vitalgen BioPharma, Regeneron, Vor Biopharma
5 FDA Decisions to Watch in Q1
BioSpace
Tue, 01/2/24 - 11:24 am
Tags:
FDA, Iovance Biotherapeutics, melanoma, lifileucel, Minerva Neurosciences, schizophrenia, roluperidone, Viatris, Mapi Pharma, MS, multiple sclerosis, GA Depot, Madrigal Pharmaceuticals, NASH, resmetirom, Vertex Pharmaceuticals, CRISPR Therapeutics, exa-cel, beta thalassemia
CRISPR eyes autoimmune disease in revamp of cell therapy plans
BioPharma Dive
Tue, 12/5/23 - 11:38 am
Tags:
CRISPR Therapeutics, cell therapy, autoimmune disease, cancer
What to know about the U.K.’s approval of the first CRISPR treatment for diseases
Nature
Fri, 11/17/23 - 10:05 am
Tags:
UK, CRISPR, gene editing, Casgevy, Vertex Pharmaceuticals, CRISPR Therapeutics
Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK
BioSpace
Thu, 11/16/23 - 10:21 am
Tags:
CRISPR, gene editing, Vertex Pharmaceuticals, CRISPR Therapeutics, UK, Casgevy, beta thalassemia
Cell & Gene Therapy Space Gears Up for First CRISPR Approval
BioSpace
Mon, 11/13/23 - 11:48 am
Tags:
CRISPR, gene therapy, cell therapy, sickle cell disease, exa-cel, Vertex Pharmaceuticals, CRISPR Therapeutics
Two Sickle Cell Disease Gene Therapies May Soon Be Approved By FDA
Forbes
Thu, 11/2/23 - 05:07 pm
Tags:
sickle cell disease, gene therapy, lovo-cel, exa-cel, Vertex Pharmaceutical, CRISPR Therapeutics, Bluebird Bio
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
Yahoo/Reuters
Tue, 10/31/23 - 09:23 pm
Tags:
Vertex Pharmaceuticals, CRISPR Therapeutics, FDA, gene therapy, exa-cel
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
Tags:
FDA, Alnylam, Onpattro, ATTR amyloidosis, Vertex Pharmaceuticals, CRISPR Therapeutics, exa-cel, Bluebird Bio, Zynteglo, sickle cell disease, Bristol Myers Squibb, 2seventy bio, Abecma, Multiple Myeloma, Amgen, Lumakras, non-small cell lung cancer, Pfizer, estrasimod, ulcerative colitis
This 1 Innovation Could Make These 2 Biotechs Soar by 2030
Motley Fool
Sun, 07/23/23 - 12:28 pm
Tags:
cell therapy, Caribou Biosciences, CRISPR Therapeutics
U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 million
Reuters
Fri, 07/14/23 - 10:07 am
Tags:
ICER, gene therapy, Vertex Pharmaceuticals, CRISPR Therapeutics, Bluebird Bio, drug pricing, sickle cell disease
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
Tags:
FDA, Eisai, Biogen, Leqembi, Alzheimer's disease, SAGE Therapeutics, zuranolone, postpartum depression, major depressive disorder, Roche, Tecentriq, non-small cell lung cancer, CRISPR Therapeutics, Bluebird Bio, lovo-cel, exa-cel, BrainStorm Cell Therapeutics, NurOwn
Gene Editing Race Between Editas and Vertex, CRISPR Heats Up
BioSpace
Mon, 06/12/23 - 09:58 am
Tags:
gene editing, Editas Medicine, Vertex Pharmaceuticals, CRISPR Therapeutics, EDIT-301, sickle cell disease, beta thalassemia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.